LONDON, UK: AstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. AstraZeneca will make payment of $425 million, for which a provision has been taken. The agreements effectively resolve the product liability claims that are currently pending in the Multidistrict Litigation in the US District Court for the…